NeoVax required a vaccine to be designed and manufactured for each patient in a phase 1 ovarian cancer trial. The study mainly tested feasibility, safety and immune response.
Trending
- Youth Sport Builds Confidence When Playing Time Is Fair
- Household Budgets Find Room in the Weekly Check-In
- Private Credit Faces Closer Scrutiny as It Grows Up
- Outdoor Time Slows Childhood Myopia Progression
- Housing First Winters Show Shelter Use Falling
- Strength Training Emerges as a Longevity Tool
- Election Officials Prepare for a New Era of Verification
- Solder, Weld, Wire: Inside the Trades Skills Shortage
